PARIS and LONDON – October 01, 2018 – Advent International, one of the largest and most experienced global private equity investors, today announced that it has completed its acquisition of Zentiva, Sanofi’s European generics business for €1,9 billion. Advent is a global investor, with over 25 years’ experience of investing in the healthcare sector. It … Continue reading Advent International completed acquisition of Zentiva from Sanofi